D M Grant1, N C Hughes, S A Janezic
1Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada. grant@sickkids.on.ca
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Genetic variations in arylamine acetyltransferase (NAT) enzymes, specifically NAT1 and NAT2, influence the metabolism of toxic compounds. Understanding these NAT gene variations is crucial for assessing individual health risks and developing diagnostic tools.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: